miacom diagnostics GmbH today announced that their proprietary hemoFISH assay for the identification and differentiation of bacterial pathogens from positive blood culture bottles is now commercially available in Canada. The hemoFISH assays are the first Health Canada approved tests out of miacoms´ diagnostic portfolio.In cooperation with Nova Century Scientific as a distributor Canada is the first country on the North American continent to have this rapid test. Nova Century Scientific is a leader in the manufacture and distribution of diagnostic kits and laboratory supplies for hospitals clinical laboratories and research institutions across Canada.
“We are happy to provide a new reliable tool for the rapid diagnostic of pathogens from blood cultures to our customers here in Canada. At NCS our mission is customer satisfaction” said Walter Schmidt CEO Nova Century Scientific “We are a company committed to meeting customer requirements and enhancing customer satisfaction through continual improvement of its products services and the quality of management.” Nova Century Scientific supports its broad range of quality laboratory products with personalized customer service and responsive technical support.
One of the first hospitals in Canada to use the new rapid test system is the Oakville Trafalgar Memorial Hospital which is part of the Halton Healthcare Services. “Having a relatively simple low capital cost test system that provides multiple pathogen identifications beyond the Gram stain within 30 minutes after a blood culture bottle turns positive may enable earlier directed antibiotic therapy even discontinuation (e.g. coagulase negative Staphylococcus). In conjunction with a local antibiogram the organism ID should facilitate treatment decisions by an antibiotic stewardship team.” highlights Dr. Neil Rau medical microbiologist and infectious diseases specialist.
The miacom assay combines a new way of sample handling with a specific optical marking of the pathogenic agents aiming for an identification and differentiation of various bacteria in 30 minutes. The assay can be easily implemented in nearly every laboratory since it does not require complicated hardware or special environment conditions.
“We´re proud to be able to offer practical solutions for special need by approved tests that are truly unique in the market” said Dr. Mirko Stange CEO of miacom diagnostics. For full diagnostic range the following products will be available: hemoFISH Gram (-) Panel (identification of Gram negative bacteria) hemoFISH Gram (+) Panel (identification of Gram positive bacteria) and hemoFISH Masterpanel (identification of Gram negative bacteria & Gram positive bacteria).
“We are happy to provide a new reliable tool for the rapid diagnostic of pathogens from blood cultures to our customers here in Canada. At NCS our mission is customer satisfaction” said Walter Schmidt CEO Nova Century Scientific “We are a company committed to meeting customer requirements and enhancing customer satisfaction through continual improvement of its products services and the quality of management.” Nova Century Scientific supports its broad range of quality laboratory products with personalized customer service and responsive technical support.
One of the first hospitals in Canada to use the new rapid test system is the Oakville Trafalgar Memorial Hospital which is part of the Halton Healthcare Services. “Having a relatively simple low capital cost test system that provides multiple pathogen identifications beyond the Gram stain within 30 minutes after a blood culture bottle turns positive may enable earlier directed antibiotic therapy even discontinuation (e.g. coagulase negative Staphylococcus). In conjunction with a local antibiogram the organism ID should facilitate treatment decisions by an antibiotic stewardship team.” highlights Dr. Neil Rau medical microbiologist and infectious diseases specialist.
The miacom assay combines a new way of sample handling with a specific optical marking of the pathogenic agents aiming for an identification and differentiation of various bacteria in 30 minutes. The assay can be easily implemented in nearly every laboratory since it does not require complicated hardware or special environment conditions.
“We´re proud to be able to offer practical solutions for special need by approved tests that are truly unique in the market” said Dr. Mirko Stange CEO of miacom diagnostics. For full diagnostic range the following products will be available: hemoFISH Gram (-) Panel (identification of Gram negative bacteria) hemoFISH Gram (+) Panel (identification of Gram positive bacteria) and hemoFISH Masterpanel (identification of Gram negative bacteria & Gram positive bacteria).